Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2003-6-10
pubmed:abstractText
To characterize altered alveolar transfer to solute in bleomycin (BLM)-injured lungs, eight dogs underwent a gadolinium diethylenetriaminepentaacetic acid aerosol (Gd-AS) magnetic resonance imaging study before and on Days 7 and 40 after tracheal instillation of BLM (0.75 mg) in the left lungs. Consecutive fast-gradient echo magnetic resonance imaging was acquired during and after spontaneous inhalation of 200-mM Gd-AS. The slope (Kep) and clearance half-time (T1/2) of logarithmic regression lines for clearance curves were estimated. Histology on Day 40 was compared with that on Day 7 in another three dogs. On Days 7 and 40, Gd-AS deposition was heterogeneously reduced in the affected lungs. On Day 7 with multifocal intraalveolar exudative changes, Kep in affected areas was significantly increased compared with baseline (2.5 x 10(-3) minutes(-1) +/- 0.3 versus 1.7 x 10(-3) minutes(-1) +/- 0.2, p < 0.0001), with significant decrease in T1/2 (121.6 +/- 19.7 minutes vs. 170.4 +/- 15.8 minutes, p < 0.001). However, on Day 40 with multifocal interstitial fibrosis, Kep and T1/2 were recovered toward baseline. BLM-injured lungs can be characterized by accelerated Gd-AS clearance during the acute exudative phase and their recovery during the chronic fibrotic phase. This technique is acceptable for monitoring alveolar transfer changes in BLM-injured lungs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1073-449X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1704-10
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12615626-Acute Disease, pubmed-meshheading:12615626-Administration, Inhalation, pubmed-meshheading:12615626-Aerosols, pubmed-meshheading:12615626-Animals, pubmed-meshheading:12615626-Bleomycin, pubmed-meshheading:12615626-Chronic Disease, pubmed-meshheading:12615626-Contrast Media, pubmed-meshheading:12615626-Disease Models, Animal, pubmed-meshheading:12615626-Dogs, pubmed-meshheading:12615626-Gadolinium DTPA, pubmed-meshheading:12615626-Instillation, Drug, pubmed-meshheading:12615626-Linear Models, pubmed-meshheading:12615626-Magnetic Resonance Imaging, pubmed-meshheading:12615626-Metabolic Clearance Rate, pubmed-meshheading:12615626-Pulmonary Alveoli, pubmed-meshheading:12615626-Respiratory Distress Syndrome, Adult, pubmed-meshheading:12615626-Severity of Illness Index, pubmed-meshheading:12615626-Time Factors, pubmed-meshheading:12615626-Trachea
pubmed:year
2003
pubmed:articleTitle
Altered clearance of gadolinium diethylenetriaminepentaacetic acid aerosol from bleomycin-injured dog lungs: initial observations.
pubmed:affiliation
Department of Radiology, Yamaguchi University School of Medicine, 1-1-1 Minamikogushi, Ube, Yamaguchi 755-8505, Japan. sugar@po.cc.yamaguchi-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't